Has Julie Stackhouse received payments from drug or device companies?

Yes. Drug and device makers reported $3,723 in general payments to Julie Stackhouse across 127 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Julie Stackhouse did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Julie Stackhouse come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Julie Stackhouse

Medical · Roseville, CANPI 1447275268

Payments from drug & device makers

$3,723in general payments, 2019–2025

Across 127 payments — averaging $29.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Electronic Waveform Lab, Inc.$805
Boston Scientific$721
Medtronic$394
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$352
Painteq LLC$233
Saluda Medical Americas, Inc.$187
plus $1K from 16 others

What the payments were for

Food & beverage$3,723100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Electronic Waveform Lab, Inc.	17	$805
Boston Scientific	16	$721
Medtronic	17	$394
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	21	$352
Painteq LLC	3	$233
Saluda Medical Americas, Inc.	3	$187
Relievant Medsystems, Inc.	9	$181
Collegium Pharmaceutical, Inc.	9	$149
Si-bone, Inc.	2	$122
Scilex Pharmaceuticals Inc.	6	$114
Almatica Pharma LLC	6	$108
Biodelivery Sciences International, Inc.	3	$52
SPR Therapeutics, Inc	2	$45
Biohaven Pharmaceutical Holding Company Ltd.	2	$44
Vertex	2	$43
Redhill Biopharma Inc.	2	$39
Abbott	2	$34
Nalu Medical, Inc.	1	$28
Amgen	1	$21
Azurity Pharmaceuticals, Inc.	1	$20
Averitas Pharma Inc.	1	$15
Nevro Corp.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,723 in reported general payments places this provider in the 80th percentile of 2,087 medical providers in California.

See all medical providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BelbucaBuprenorphine Hcl	42	$26,512
MovantikNaloxegol Oxalate	56	$22,337
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	389	$10,409
Buprenorphine	15	$4,069
OxycontinOxycodone Hcl	12	$3,741
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	15	$3,049
Buprenorphine Hcl	78	$2,571
Gabapentin	179	$2,537
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	81	$2,061
Lidocaine	22	$1,962
Naloxone Hcl	22	$1,460
Baclofen	86	$1,182
Morphine Sulfate ErMorphine Sulfate	42	$1,125
Hydroxyzine Hcl	61	$1,051
Pregabalin	32	$834

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca	$149	$26,51242 claims
Redhill Biopharma Inc.Movantik	$39	$22,33756 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 medical providers in California.

Other medical in Roseville

Nicola LowreyOrange$655K
Justin LoveLoma Linda$553K
David DoriguzziLancaster$514K
Alison GracomIrvine$467K
Jeffrey BonnaudLos Angeles$314K
Ana TorresLaguna Beach$229K
Heather ParlettRedlands$168K
Deirdre MoxleyFullerton$149K
Tri leGardena$127K
Linda RankLadera Ranch$105K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →